Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes

Identification of a Molecular Signature in Human Type 1 Diabetes Mellitus Using Serum and Functional Genomics

(2014) X. Wang et al.   JOURNAL OF IMMUNOLOGY

Short-term IL-1β blockade reduces monocyte CD11b integrin expression in an IL-8 dependent fashion in patients with type 1 diabetes

(2010) Srinath Sanda et al.   CLINICAL IMMUNOLOGY

Failure to Preserve  -Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes

(2010) P. A. Gottlieb et al.   DIABETES CARE

Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?

(2010) Xunrong Luo et al.   IMMUNITY

Blockade of interleukin 1 in type 1 diabetes mellitus

(2010) Thomas Mandrup-Poulsen et al.   Nature Reviews Endocrinology

Immunological and Inflammatory Functions of the Interleukin-1 Family

(2009) Charles A. Dinarello   Annual Review of Immunology

New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes

(2009) H. B. Mortensen et al.   DIABETES CARE

The anti-interleukin-1 in type 1 diabetes action trial-background and rationale

(2009) Linda M.S. Pickersgill et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

(2009) Mark D. Pescovitz et al.   NEW ENGLAND JOURNAL OF MEDICINE